FD/PMA is a subclone of the interleukin-3 (IL-3)-dependent, FDC-P1 cell line, which proliferates in response t o either 12-0-tetradecanoylphorbol-13 acetate (PMA) or IL-3. While several endogenous substrates were phosphorylated in response t o protein kinase C (PKC) activation in FDC-P1, phospholipid-dependent phosphorylation in the FD/ PMA grown in PMA was not observed. Basal, phosphatidylserineindependent, and diolein-independent phosphorylation of cytosolic substrates with molecular weights of 17,52,57, and 105 Kd were enhanced in FD/PMA cells grown in PMA as compared with FDC-P1 cells cultured in IL-3. Phosphorylation of a 105-Kd substrate was enhanced in the particulate fraction of FD/PMA cells maintained in PMA. The 17-Kd substrate in FD/PMA cells comigrated with a substrate phosphorylated in a PKC-dependent manner in FDC-P1 cells. Phosphorylation of the 52-and 57-Kd substrates, but not of DC-P1 CELL IS A MURINE, myeloid cell line that F requires interleukin-3 (IL-3) for growth.' We have recently described subclones of this line, termed FD/PMA, that proliferate in response to phorbol esters as well as to IL-3.2 However, FD/PMA cells are factor-dependent because they do not proliferate in media lacking IL-3 or 12-0-tetradecanoylphorbol-13 acetate (PMA). Because phorbol esters exert their effects on cellular function by activating protein kinase C (PKC), we anticipated that the FD/PMA cell line would contain this kinase activity. Using histone as a phosphate acceptor we were unable to detect PKC-dependent phosphotransferase activity in the FD/ PMA cells maintained in PMA.' Additional evidence for a reduction of PKC in FD/PMA cells was provided by the inability of antiserum recognizing the regulatory domain of the a, p, and y isoforms of PKC to detect appreciable amounts of these isoforms. The reduction of PKC content in FD/PMA cells grown in PMA was due to exposure to PMA because FD/PMA cells cultured in IL-3 contained PKC-dependent histone phosphotransferase activity.* Because the FD/PMA cell line proliferates in PMA and phorbol esters exert their effects by activating PKC, we sought to define the mechanism(s) by which these cells could respond to PMA in the absence of PKC histone phosphotransferase activity. Comparisons were made between PKC isoform content and kinase activities in FD/ PMA and FDC-P1 cell lines. FD/PMA cells cultured in PMA, but not FDC-PI cells maintained in IL-3, contained constituitively activated, phosphatidylserine-and dioleinindependent, cytosolic and particulate kinase activities. As evidenced by differential sensitivity to H-7 and staurosporine, at least two phospholipid-independent cytosolic kinases were activated by maintenance of FD/PMA in PMA. Coincident with the induction of these kinase activities was a marked diminution in PKC-dependent phosphorylation of histone and endogenous substrates in FD/PMA cells maintained in PMA. However, Western blot analysis showed the presence of nearly equal quantities of the a and E isoforms in FDC-P1 and FD/PMAgrown in IL-3 and PMA, the 17-Kd substrate, was inhibited by H-7 and staurosporine. A portion of the PMA-induced cytosolic kinase activity coeluted with PKC on diethyl aminoethyl chromotography. While FD/PMA cells cultured in PMA contained negligible PKC-dependent phosphorylation of endogenous substrates or histone, CY and E PKC isoforms were detected by Western blot analysis. PKC phosphotransferase activity was observed in FD/PMA cells grown in PMA when peptides corresponding t o residues 720 t o 737 of PKC-c or residues 4 t o 14 of myelin basic protein were used as'substrates. These data indicate that maintenance of FD/PMA cells in PMA stimulates proliferation and markedly alters PKC substrate specificity. Generation of at least two phospholipid-independent kinases occurs in PMA-treated cells. 0 1991 by The American Society of Hematology.
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respectively. Despite the lack of histone phosphotransferase activity, FDIPMA grown in PMA contained PKCdependent phosphotransferase activity when peptides corresponding to residues 720 to 737 of PKC-E (€-peptide) or a peptide corresponding to residues 4 to 14 of myelin basic protein (MBP,,,) were used as substrates. Thus, maintenance in PMA induced expression of at least two kinase activities and drastically altered PKC substrate specificity.
WAYS ET AL
rupted by sonication with a 10-second burst. The homogenate was centrifuged at 100,000g for 60 minutes. The supernatant, termed cytosol, was removed. The pellet was rinsed with buffer A, omitting the sucrose, and resuspended in buffer A with 0.1% Triton X-100 (Research Products International Corp, Mount Prospect, IL), without the sucrose. The pellet was suspended by sonicating as described above. The samples were incubated at 4°C for 45 minutes before centrifugation at 100,000g for 60 minutes. The supernatant containing the solubilized particulate fraction was removed. In certain experiments, a total cell solubilized fraction was prepared by sonicating the cells in buffer A containing 0.1% Triton X-100. After 45 minutes of incubation at 4"C, the sample was centrifuged at 100,OOOg for 60 minutes, yielding in the supernatant fraction both cytosolic and solubilized particulate fractions. The protein content of the samples was determined as previously described. Proteins were separated using a 5% and 10% or 12% polyacrylamide stacking and running gel, respectively, according to the method of Laemmli., The gels were stained, destained, dried, and exposed to Kodak XAR film (Eastman Kodak, Rochester, NY) for 16 hours at -70°C. Antibody preparation and Western blot analysis. QEE-GEYYLVPIPEC (PKC-a, regulatory domain), AENKVISPSE-DRRQC (residues 313 to 326 of PKC-a, V, region), GPKTPEEK-TANTISKFDC (residues 313 to 329 of PKC-p, V, region), NYPLELYERVRTGC (residues 306 to 318 of PKC-y, V, region), and NQEEFKGFSYFGEDLMP (residues 720 to 737 of PKC-E, V, region) were used for antibody preparation. Regulatory,' y / p / a~ and E' peptides have been previously used to successfully generate domain-and isoform-specific antisera. A cysteine residue was added to the carboxy terminal of all peptides except PKC-E to facilitate coupling of the peptide to keyhole limpet hemocyanin (KLH). Glutaraldehyde was used to couple the PKC-E peptide to KLH' while m-maleimidobenzyl-N-hydroxysuccinimide ester was used for coupling all other peptides to KLH.8 The conjugates (1.7 mg) were dissolved in phosphate-buffered saline (PBS), mixed with Freund's adjuvant, and administered intramuscularly into female New Zealand white rabbits. A booster injection (1.7 mg peptide, intramuscularly) in incomplete Freund's adjuvant was administered 6 weeks after the initial injection and every 4 weeks thereafter. Blood was obtained 10 to 14 days after each boost. In all experiments, the serum from a single bleed was used. In certain instances, the IgG fraction was partially purified by protein A chromatography according to instructions of the manufacturer (Pierce, Rockford, IL). Western blotting was performed as previously described., In certain experiments, Western blot analysis was performed using samples in which protein denaturation occurred rapidly after cell disruption. To prepare the sample, 0.8 x lo6 cells were added to a solution containing 2% sodium dodecyl sulfate (SDS), 100 mmol/L dithiothreitol, 60 mmol/L Tris-HCL, pH 6.8, 0.1% bromophenol blue, and 7.5% glycerol that had been previously heated to 110°C. The cells were disrupted with a 10-second burst at 70% maximal power with a sonic disrupter and 10 passages through a 25-gauge needle. The sample was boiled for 10 minutes and debris was removed by centrifugation at 10,OOOg for 10 minutes at 4°C. The supernatant was used for Western blot analysis. The Phosphorylation of endogenous substrates.
antisera were used at the following concentrations: regulatory 1:500, a 1:4,000, p 1:6,000, y 1:2,000, and E 1:3,000. The specificity of proteins detected by this method was confirmed by preabsorption of the antisera with the peptide used to prepare the antiserum. Equal volumes of the antiserum and peptide (8 mg/mL) were incubated for 60 minutes at 22°C before exposure to the blot. Specificity was confirmed if detection of the protein was blocked by preabsorption of the antisera with the peptide. In addition, the 7, p, and a antisera recognized peaks I, 11, and I11 of PKC activity, respectively, after hydroxyapatite chromatography. The PKC-E antiserum recognized an 87-Kd protein that comigrated with the p isoform as has been previously de~cribed.~ As previously published: cellular extracts, 40 pg, were incubated with 20 mmol/L Tris-HCL pH 7.4, 0.2 mmol/L EDTA, 0.05 mmol/L EGTA, 10 mmol/L MgCI,, 0.75 mmol/L CaCI,, and either 100 pg of protamine or 40 pg of histone V-S, epeptide, or MBP,,,'" in a total volume of 100 )LL. The sequences of e-peptide and MBP,,, are ERMRPRKRQGSVRRRV and QKRPSQRSKYL, respectively. The epeptide corresponds to residues 720 to 739 of PKC-E.' To activate PKC, phosphatidyl serine and diolein were prepared as previously described2 and added at concentrations of 5 pg and 1.2 pg/lOO pL, respectively.
The samples were warmed to 27°C for 1 minute and the reaction was initiated by adding 10 pmol/L [y-"P]-ATP, 3 pCi/tube. For samples containing histone, the reaction was terminated after an 8-minute period by adding an equal volume of ice-cold 60% acetic acid containing 1 mmol/L ATP. Forty-microliter aliquots were applied in duplicate to 2 x 2 cm squares of phosphocellulose paper and rinsed in acetic acid. For reactions using e-peptide, MBP,,,, or protamine as substrates, Whatman 3 mm paper (Whatman, Maidstone, UK) was spotted with 30 pL of the reaction mixture. The papers were immediately placed in a bath containing 10% trichloracetic acid (TCA). The papers were washed two additional times in 10% TCA. Radioactivity associated with the papers was quantitated by counting in a p-counter.
Cellular extracts were applied at a protein concentration of 1 mg/mL in a buffer containing 20 mmol/L Tris-HC1, pH 7.4; 5 mmol/L 2-mercaptoethanol; and 0.01% Triton X-100 (vol/vol) (buffer B) to a 2 X 0.9 cm column containing DEAE cellulose previously equilibrated with buffer B. After sample application, the column was sequentially washed with 20 mL of buffer B and 20 mL of buffer B containing 20 mL NaCI. Elution of PKC was performed isocratically with 20 mL of 120 mmol/L NaCl in buffer B. One-milliliter fractions were collected, and 30-pL aliquots of each fraction were analyzed for PKC activity.
Cellular RNA was isolated from 10' cells electrophoresed on agarose gels, blotted onto nitrocellulose filters, and hybridized with PKC cDNA probes as previously described.'." PKC activivity.
DEAE chromatography.
Northern anulysis.
RESULTS
Because FD/PMA cells lacked PKC-dependent histone phosphotransferase activity, we examined whether the PKC-dependent phosphorylation of endogenous substrates was similarly affected. PKC-dependent phosphorylation of several endogenous substrates was observed in cytosol derived from FDC-P1 cells (Fig 1A) . Although phosphorylation of a 40-Kd substrate was enhanced in the particulate fraction by inclusion of PKC activators (Fig lB) , the overall level of PKC-stimulated phosphorylation was much less than observed in the cytosolic fraction. However, in FD/ PMA cells, inclusion of PKC activators did not enhance phosphorylation of endogenous substrates (Fig 1) . The lack of phospholipid-dependent phosphorylation of endogenous substrates was not due to an intrinsic difference between FDC-PI and FD/PMA cell lines. FD/PMA maintained in IL-3 displayed PKC-dependent phosphorylation of endogenous substrates which was identical to that of the FDC-PI cell line (data not shown). Interestingly, in the cytosolic fraction from FD/PMA cells maintained in PMA, the basal phosphorylation of substrates with approximate molecular weights of 105, 57, 52, and 17 Kd was increased when compared with FDC-P1 cells (Fig 1A) . The 17-Kd substrate appeared as a doublet when higher percentage polyacrylamide gels were used and phosphorylation of both proteins was enhanced in FD/PMA cells maintained in PMA. The 17-Kd substrate was also phosphorylated in a PKCdependent fashion in FDC-P1 cells. In the particulate fraction, phosphorylation of a 105-Kd substrate was also increased after growth of FD/PMA in PMA (Fig 1B) . The enhanced, basal phosphorylation of these substrates was secondary to growth in PMA because the enhancement was not observed in FD/PMA grown in IL-3 (data not shown).
We examined whether PKC inhibitors would alter the basal phosphorylation of substrates in FD/PMA cells maintained in PMA. At concentrations exceeding 25 nmol/L, staurosporine, an inhibitor of PKC,'* inhibited phosphorylation of the 57-and 52-Kd substrates but not of the 17-Kd substrate (Fig 2A) . H-7, another inhibitor of PKC,'-' at concentrations exceeding 10 pmol/L likewise diminished phosphorylation of the 57-and 52-Kd substrates but not of the 17-Kd substrate (Fig 2B) . Given the higher concentrations of H-7 and staurosporine required to inhibit phosphorylation of the 52-and 57-Kd substrates than those required to inhibit purified PKC,'**" the ability of these compounds to inhibit phosphorylation of these substrates does not necessarily imply that these events are mediated by a PKC-dependent mechanism. The inability of these agents to inhibit phosphorylation of the 17-Kd substrate while diminishing phosphorylation of the 52-and 57-Kd substrates indicated that more than one kinase was activated in FD/PMA cells cultured in PMA. Also, the inability of H-7 and staurosporine to inhibit phosphorylation of the 17-Kd substrate showed that a kinase other than PKC was responsible for this phosphorylation.
At least a portion of the constituitively activated cytosolic kinase activities in FD/PMA cells coeluted with PKC on DEAE chromatography (Fig 3) . PKC-dependent phosphorylations are observed in the DEAE eluate from FDC-PI cells while none are seen in the FD/PMA extract (Fig 3) . However, it was observed that in the same fractions containing PKC activity in FDC-P1 cells, enhanced basal phosphorylation of several substrates with molecular weights of 200, 57, 50, 36, and 30 Kd were observed in FD/PMA cells grown in PMA. While enhanced basal phosphorylation of substrates in FD/PMA was always observed and eluted at the same position as PKC in FDC-P1 cells, there was minor variability in the extent of phosphorylation of individual substrates between experiments.
PKC content was examined in FDC-PI and FD/PMA cell lines by Western blot analysis using isofom-specific antisera (Fig 4) . The a isoform was detected in approxi- mately equal amounts in both cell lines while the p isoform was not detected. Northern blot analysis showed equal amounts of messenger RNA (mRNA) transcripts for the a isoform in FDC-P1 grown in IL-3 and FD/PMA maintained in either IL-3 or PMA. PKC-P transcripts were not detected in either cell line. In the same experiment, Western blot analysis was performed using antiserum directed against a conserved region in the regulatory domain of PKC that recognizes the a, p, and y isoforms? As we have previously found,' PKC content in FD/PMA cultured in PMA detected by this antiserum was substantially reduced as compared with the PKC content in FD/PMAcultured in PMA. These results do not agree with those obtained with the a isoform-specific antiserum. While an explanation for this discrepancy has yet to be elucidated, similar alterations in antigenic recognition of PKC in PMA-treated cells have been reported e1~ewhere.l~ Additionally, use of the regulatory domain-specific antiserum failed to identify evidence of enhanced proteolysis of PKC in FD/PMA cultured in PMA. While this antiserum recognizes a 30-Kd protein from trypsin-treated PKC," the existence of such a protein was not observed in FD/PMA cells cultured in PMA.
On occasion, Western blot analysis with PKC-y antiserum yielded positive results in FD/PMA grown in PMA. However, in the majority of experiments this isoform was not detected in FDC-PI or FD/PMA cell lines. Use of a second PKC-y antiserum raised against a carboxy terminal epitope that was generously provided by Dr Peter Parker (Imperial Cancer Research Fund, London, UK) did not recognize this isoform in either cell line. Finally, using Northern blot analysis, mRNA transcripts for this isoform were not identified.
Using antiserum specific for the E isoform we examined FDC-P1 and FD/PMA for the presence of this isoform ( Fig   5) . Despite being able to measure this isoform in brain extracts, initial attempts to measure PKC-E in cytosolic or solubilized particulate fractions were not successful. However, the finding of equal amounts of mRNA transcripts encoding PKC-E found in FDC-PI maintained in IL-3 and FD/PMA grown in either PMA or IL-3 suggested the presence of this isoform (data not shown). PKC-E undergoes proteolytic degradation that could interfere with measurement of this i~oform.~ To minimize degradation of PKC-E occurring during sample preparation, proteins were rapidly denatured after cell disruption. Using this method, PKC-E was found in extracts from FDC-PI grown in IL-3 and FD/PMA cultured in IL-3 or PMA (Fig 5) . The difficulty in measuring PKC-E in cellular fractions was cell-specific because this isoform could be detected in cytosolic and solubilized particulate fractions derived from neuronal tissue (Fig 5, brain e~tract) .~.'~.'' Using histone as a substrate, PKC-dependent phosphotransferase activity was markedly diminished in FD/ PMA grown in PMA. ' We have found in the monoblastoid U937 cell that exposure to PMA alters PKC substrate specificity as evidenced by a reduction in histone phosphorylation despite the presence of PKC-dependent phosphorylation of a peptide corresponding to residues 720 to 737 of PKC-e." We examined whether PKC substrate specificity was likewise altered in FD/PMA cells grown in PMA. PKC-dependent phosphorylation of histone was markedly diminished in FD/PMA grown in PMA (Fig 6A) . However, PKC activity was readily detected in FD/PMA grown in PMA when either the €-peptide or MBP,,, were used as substrates (Fig 6B and C, respectively) . Altered PKC substrate specificity (eg, loss of histone phosphorylation) was due to exposure to PMA because FD/PMA cultured in IL-3 contained PKC-dependent histone phosphotransferase activity (Fig 6A) . Only a modest decrease in the phospholipid-independent phosphorylation of protamine was observed in FD/PMA maintained in PMA ( Fig  6D) . Sample: The left most lane of each autoradiogram contains partially purified rat brain cytosol as a positive control for PKC. The =5O-Kd protein detected with the antiserum against the regulatory domain of PKC is not specific because preabsorption of the antibody with the peptide it was generated against did not abolish detection of this protein.
DISCUSSION
In FD/PMA cells cultured in PMA, cytosolic and particulate, phosphatidylserine-and diolein-independent, constituitively activated kinases were observed as shown by enhanced basal phosphorylation of several endogenous substrates. These kinase activities were not detected in the Antiserum:
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Sample: FDC-PI or FD/PMA cell lines cultured in IL-3. Thus, PMA was required to generate these activities. The mechanism by which the kinases were activated in FD/PMA cells remains unknown. An obvious possible mechanism would be generation of m kinase by PMA-stimulated proteolytic degradation of PKC.'R-20 However, we were unable to detect proteolysis of PKC in FD/PMA cells either by Western analysis using regulatory domain-specific antiserum or by measuring phosphatidylserine-and diolein-independent histone phosphotransferase activity eluting from DEAE chromatography at an NaCl concentration of 200 mmol/L (data not shown). In other cell types, we' ' and othersu*23 have described particulate-associated, phosphatidylserineand diolein-independent kinase activities that are generated after an acute exposure to PMA. In one case, the mechanism of persistent activation of PKC was suggested to be through a PMA-induced association of the kinase with phospholipids.22 Given the hydrophobic nature of this complex, it is unknown whether the same mechanism could be responsible for generation of the cytosolic kinase activities. Coelution on DEAE chromatography of enhanced basal phosphorylation of endogenous substrates in FD/ PMA cells grown in PMA with PKC derived from FDC-P1 cells suggested that a persistently activated form of PKC could be responsible for these phosphorylations. Alternatively, the activity could be due to a kinase indirectly activated via a phosphorylation cascade initiated by PKC activation such as has been described for raf, S6, or MAP kinase^^^'^^ or due to a kinase directly activated by PMA in a PKC-independent manner. The inability of H-7 and staurosporine to inhibit phosphorylation of the 17-Kd cytosolic substrate in FD/PMA cells maintained in PMA indicated that a kinase other than PKC had been activated.
Demonstration of the ci and E isoforms in FD/PMA by Western blot analysis indicated the availability of PKC for stimulation by PMA. However, we have as yet been unable to detect PKC-dependent histone phosphotransferase activ- D DEAE Fraction Number ity or phospholipid-dependent phosphorylation of endogenous substrates in FD/PMA. The mechanism underlying this apparent downregulation of kinase activity may be mediated by a marked alteration in kinase substrate specificity. Preservation of epeptide and MBP,,, phosphorylation supports this contention. We have recently reported a similar alteration in PKC substrate specificity in the human U937 monoblastoid cell after an acute exposure to PMA.I5 In BC3H-1 myocytes drastic alterations in PKC substrate specificity have also been observed after exposure to PMA.27 While the mechanism responsible for alterations in substrate specificity is unknown, the recent observation that incubation of PKC with PMA and phospholipids leads to an inactivation of histone phosphotransferase activity without an absolute loss of kinase content may be of relevance.% Perhaps association with phospholipids interferes with phosphorylation of histone but spares intrinsic kinase activity and kinase-dependent phosphorylation of small peptides. As evidenced by the lack of Ca2+ dependency, the mechanisms governing the PKC-dependent phosphorylation of small peptides are fundamentally different from those responsible for phosphorylation of larger, positively charged substrates such as histone." It is obvious that further studies will need to be performed to substantiate this hypothesis. Another possible explanation for the selective phosphorylation of €-peptide and MBP,,, is that the 6, 5, or q isoforms exist in FD/PMA and are responsible for this action. It has been shown that the E isoform that is also a member of the calcium-independent subfamily of PKC has markedly different substrate specificity than the a, p, and y isoforms.' PKC-E does not phosphorylate histone but does phosphorylate small peptide substrate^.'^^ However, it is doubtful that the E isoform was responsible for phosphorylation of MBP,,, or €-peptide because this isoform could not be detected by Western blot analysis in cellular fractions. Thus, if PMA treatment selectively inactivates the a and E isoforms but the S , 5 , q, or an as yet undescribed isoform are spared then phosphorylation of epeptide and MBP,.,, would occur without the concomitant phosphorylation of histone. The ability to detect PKC-a but not the E isoform in cell fractions shows that these isoforms differ in susceptibility to degradation after cellular disruption. Differential sensitivity among the isoforms to TPA-induced downregulation has been noted in other cell^.^^^'^ The preferential loss of PKC-E during cell fractionation suggests that this isoform was either more sensitive to a single degradative process affecting all isoforms or separate degradative mechanisms affect the cx and E isoforms. Because alterations in PKC-E content could arise from either changes occurring in the intact cell or degradation occurring during cellular fractionation, caution must be exercised in interpreting results obtained with this isoform using cell fractions.
In summary, we have described the existence of a constituitively activated kinase activity in FD/PMA cells maintained in PMA that coeluted with PKC on DEAE chromatography. In addition, constituitive activation of another kinase that was not inhibited by H-7 or staurosporine and phosphorylates a 17-Kd substrate was observed in FD/PMA cells maintained in PMA. PKC substrate specificity was shown to be drastically altered by maintenance of cells in PMA, as evidenced by the lack of histone phosphotransferase activity and PKC-dependent phosphorylation of endogenous substrates despite the presence of kinase as determined by Western blot analysis using isoformspecific antisera and PKC-dependent phosphotransferase activity when the €-peptide or MBP,,, were used as substrates. Despite the drastic alteration in PKC signal transduction pathway, PMA was still able to exert a biologically significant event (eg, sustenance of FD/PMA growth). Further experiments will need to be undertaken to determine whether PMA-induced proliferation was due to continuous activation of the cx and E isoforms or was secondary to generation of the phospholipid-independent kinase activities. In sum, these findings underscore the complexity of the PKC signal transduction and provide evidence for multiple pathways within this system by which PMA may exert effects on cellular function.
